These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15541811)

  • 21. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.
    Marsit CJ; Hasegawa M; Hirao T; Kim DH; Aldape K; Hinds PW; Wiencke JK; Nelson HH; Kelsey KT
    Cancer Res; 2004 Dec; 64(23):8702-7. PubMed ID: 15574780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal cortical dysplasia of Taylor's balloon cell type: mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis.
    Becker AJ; Urbach H; Scheffler B; Baden T; Normann S; Lahl R; Pannek HW; Tuxhorn I; Elger CE; Schramm J; Wiestler OD; Blümcke I
    Ann Neurol; 2002 Jul; 52(1):29-37. PubMed ID: 12112044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
    Kitaguchi S; Takeshima Y; Nishisaka T; Inai K
    Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder.
    Edwards J; Duncan P; Going JJ; Watters AD; Grigor KM; Bartlett JM
    J Pathol; 2002 Apr; 196(4):380-5. PubMed ID: 11920732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.
    Konishi H; Sugiyama M; Mizuno K; Saito H; Yatabe Y; Takahashi T; Osada H; Takahashi T
    Oncogene; 2003 Mar; 22(12):1892-905. PubMed ID: 12660825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer.
    Poursoltan P; Currey N; Pangon L; van Kralingen C; Selinger CI; Mahar A; Cooper WA; Kennedy CW; McCaughan BC; Trent R; Kohonen-Corish MR
    Lung Cancer; 2012 Aug; 77(2):272-6. PubMed ID: 22542170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased expression of the SIN3A gene, a candidate tumor suppressor located at the prevalent allelic loss region 15q23 in non-small cell lung cancer.
    Suzuki H; Ouchida M; Yamamoto H; Yano M; Toyooka S; Aoe M; Shimizu N; Date H; Shimizu K
    Lung Cancer; 2008 Jan; 59(1):24-31. PubMed ID: 17854949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis with a TSC2 gene.
    Maruyama H; Seyama K; Sobajima J; Kitamura K; Sobajima T; Fukuda T; Hamada K; Tsutsumi M; Hino O; Konishi Y
    Mod Pathol; 2001 Jun; 14(6):609-14. PubMed ID: 11406664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
    Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S
    Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer.
    Sekine I; Sato M; Sunaga N; Toyooka S; Peyton M; Parsons R; Wang W; Gazdar AF; Minna JD
    Oncogene; 2005 Apr; 24(16):2735-8. PubMed ID: 15735765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer.
    Xinarianos G; McRonald FE; Risk JM; Bowers NL; Nikolaidis G; Field JK; Liloglou T
    Hum Mol Genet; 2006 Jul; 15(13):2038-44. PubMed ID: 16698880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease.
    Behrens C; Travis LB; Wistuba II; Davis S; Maitra A; Clarke EA; Lynch CF; Glimelius B; Wiklund T; Tarone R; Gazdar AF
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1027-35. PubMed ID: 11045784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation detection in tumor suppressor genes using archival tissue specimens.
    Astrinidis A; Henske EP
    Methods Mol Med; 2006; 126():185-96. PubMed ID: 16930013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation of RAS association domain family protein 1A as a biomarker of lung cancer.
    Grote HJ; Schmiemann V; Geddert H; Bocking A; Kappes R; Gabbert HE; Sarbia M
    Cancer; 2006 Apr; 108(2):129-34. PubMed ID: 16444703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypermethylation of the GATA genes in lung cancer.
    Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
    Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of p53 mutations in histologically normal lung tissues and lung tumors from non-small cell lung cancer patients.
    Gao W; Mady HH; Melhem MF; Keohavong P
    Mol Carcinog; 2009 Jul; 48(7):633-41. PubMed ID: 19072763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
    Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ
    Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer.
    Kikuchi S; Yamada D; Fukami T; Masuda M; Sakurai-Yageta M; Williams YN; Maruyama T; Asamura H; Matsuno Y; Onizuka M; Murakami Y
    Clin Cancer Res; 2005 Apr; 11(8):2954-61. PubMed ID: 15837747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer.
    Murakami Y
    Oncogene; 2002 Oct; 21(45):6936-48. PubMed ID: 12362275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.